NASDAQ · Biotechnology

PHVS (PHVS) Stock

$32.62 -3.05% NASDAQ: PHVS Healthcare

Valuation

MetricValue
Price$32.62
Market Cap$2.28B
P/E Ratio-9.75
P/B Ratio6.99
P/S Ratio0.00
EPS (TTM)$-2.97
52-Week High$36.23
52-Week Low$16.72
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-64.94%
ROA-58.47%
ROCE-62.73%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio9.97

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-54.0M$-87.0M$-97.0M$-146.0M$-170.0M
Net Profit$-43.0M$-76.0M$-101.0M$-134.0M$-176.0M
EPS$-1.41$-2.27$-2.63$-2.48$-2.97
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$212.0M$168.0M$399.0M$291.0M$301.0M
Total Liabilities$7.0M$18.0M$15.0M$24.0M$30.0M
Cash$209.0M$162.0M$391.0M$281.0M$292.0M
Borrowings$0$0$0$1.0M$1.0M

Latest News

Here's Why Pharvaris N.V. (PHVS) is a Great Momentum Stock to Buy Zacks · Jul 15, 2026 IBM downgraded, Cava upgraded: Wall Street's top analyst calls The Fly · Jul 15, 2026 Wells Fargo Initiates Coverage on Pharvaris With Overweight Rating, $55 Price Target MT Newswires · Jul 15, 2026 Wall Street Analysts Believe Pharvaris (PHVS) Could Rally 36.16%: Here's is How to Trade Zacks · Jul 14, 2026 Why This Biotech, Up 12% Since Its Breakout, Yo-Yoed On A Key FDA Development Investor's Business Daily · Jul 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-45.0M$-67.0M$-93.0M$-120.0M$-137.0M
Investing Cash Flow$0$0$0$-1.0M$0
Financing Cash Flow$-13.0M$-1.0M$-17.0M$1.0M$-11.0M
Net Cash Flow$111.0M$-48.0M$229.0M$-111.0M$11.0M
Free Cash Flow$-45.0M$-67.0M$-93.0M$-121.0M$-137.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-9.08%
Quick Ratio11.24
Interest Coverage—
Return 1Y48.62%
Return 3Y107.86%
Return 5Y136.97%

Ownership

Insiders Held6.14%
Institutions Held85.31%
Institutions Float Held90.89%
Institutional HolderSharesReport Date
General Atlantic, L.P.8,031,2522026-03-31
FMR, LLC6,284,4722026-03-31
Foresite Capital Management IV, LLC4,778,5812026-03-31
venBio Partners LLC4,639,3042026-03-31
Viking Global Investors, L.P.3,653,3102026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ARDX $5.09 +0.49% 11.04 $1.26B 0.00%
BCRXBioCryst Pharmaceuticals, Inc. $9.75 +4.39% -5.40 $2.48B 0.00%
IMNM $23.22 +2.83% -8.13 $2.22B 0.00%
MAZE $27.88 -2.82% -8.11 $1.54B 0.00%
NTLA $10.89 +2.06% -3.55 $1.22B 0.00%

About PHVS

PHVS stock trades at $32.62 with a market capitalization of $2.28B. The stock is valued at a price-to-earnings (P/E) ratio of -9.75, price-to-book of 6.99, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $16.72 and $36.23, and currently trades 10.0% below its 52-week high.

On profitability, PHVS generates a return on equity (ROE) of -64.94%, return on capital employed of -62.73%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides